Market cap
$1.8M
Shares out
541K

Why is NUWE stock moving today?

PRago
Nuwellis to Host Webinar Discussing ULTRA-Peds Registry Results and Aquadex Performance in Critically Ill Pediatric Patients

Live discussion will feature study investigators examining clinical findings, treatment outcomes, and the role of ultrafiltration in pediatric fluid management MINNEAPOLIS, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced that it will host a live educational webinar, "ULTRA-Peds Results Analysis and Discussion," on December 1, 2026, at 1:00 p.m. Eastern Time. The event will feature a panel of lead and contributing authors of the multicenter study titled "Kidney Support in Infants and Children using Aquadex: Findings from the ULTRA-Peds Registry," whi

All NUWE news

When does Nuwellis report earnings?

Nuwellis last reported on Nov 12, 2026, the date it announced on Nov 4, 2026. Before that it reported on May 12, 2026 and Mar 10, 2026.

NUWE earnings history

Financial highlights

Full financials
Revenue, TTM
$9.01M
Revenue growth
+10.3%
Net income, TTM
-$13.76M
Net margin
-152.8%
Free cash flow, TTM
-$12.38M
Cash
$8.29M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

Latest news

25 items

NUWE rankings

News · 26 weeks54+200%
2026-05-24: 22026-05-31: 52026-06-07: 42026-06-14: 22026-06-21: 42026-06-28: 12026-07-05: 22026-07-12: 12026-07-19: 12026-07-26: 42026-08-02: 42026-08-09: 42026-08-16: 12026-08-23: 42026-08-30: 02026-09-06: 12026-09-13: 22026-09-20: 02026-09-27: 12026-10-04: 12026-10-11: 02026-10-18: 12026-10-25: 12026-11-01: 22026-11-08: 42026-11-15: 2
2026-05-242026-11-15
Mix1990d
  • Other9(47%)
  • SEC Filings7(37%)
  • Earnings2(11%)
  • Leadership1(5%)
Activity · 52 weeks10481 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Nuwellis Inc. (NUWE) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company listed on NASDAQ. In the last 30 days Quantisnow tracked 10 wire items for NUWE, including 4 SEC filings, 4 press releases and news items and 2 earnings updates. The most recent was published Nov 19, 2026.

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Brunei, Germany, Greece, Hong Kong, India, Israel, Italy, Palestine, Singapore, Spain, Switzerland, Thailand, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

NUWE FAQ

9 questions
  • What does Nuwellis Inc. do?
    Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria...
  • What is NUWE revenue?
    Nuwellis Inc. (NUWE) reported $9.01M of revenue for the twelve months ended Sep 30, 2026. That is up 10.3% from the year before. Revenue for fiscal 2025 was $8.27M.
  • Is NUWE profitable?
    No. Nuwellis Inc. reported a net loss of $13.76M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does NUWE have?
    Nuwellis Inc. reported $8.29M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does NUWE stock trade?
    Nuwellis Inc. (NUWE) is listed on NASDAQ.
  • What sector and industry is NUWE in?
    Nuwellis Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.
  • What are analysts saying about NUWE?
    Nuwellis Inc. has had 1 recent analyst action on file. The most recent action was from ROTH MKM: Buy with a $17.00 price target on 2024-07-29. Recent price targets cluster around $17.00.
  • What companies are similar to NUWE?
    Notable peers in the same industry include BAX (Baxter International Inc.), MDT (Medtronic plc.), FMS (Fresenius Medical Care AG), OM (Outset Medical Inc.). Compare NUWE side-by-side with any of them on Quantisnow.
  • How can I track NUWE on Quantisnow?
    Quantisnow aggregates Nuwellis Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NUWE to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change